The Cancer Control and Outcomes Program is one of three scientific programs in the ECOG-ACRIN Cancer Research Group. This program addresses a broad range of research aims, primarily those that are part of the cancer control continuum, which is widely recognized throughout the research community as including: cancer prevention, early detection, diagnosis and surveillance, treatment, and survivorship.
ECOG-ACRIN’s Cancer Control and Outcomes program aims to significantly reduce the burden of cancer on individual and societal levels by designing and conducting practice-changing clinical trials that span the entire continuum, from prevention through survivorship, in the communities where individuals receive their care. This program also engages in health equity research by studying determinants of disparities in cancer clinical trials, promoting accrual, and addressing the unique needs of younger and older adults diagnosed with cancer. Across the program, there is an emphasis on cancer care delivery research. For more information about the cancer control continuum, visit the NCI website.
Lynne I. Wagner, PhD
Wake Forest University and the Comprehensive Cancer Center of Wake Forest University
Mitchell D. Schnall, MD, PhD
University of Pennsylvania
There are five large scientific committees within the Cancer Control and Outcomes Program. Each committee has its own scientific aims and subcommittees. Committee and subcommittee memberships are cross-populated with the other two scientific programs—Therapeutic Studies and Biomarker Sciences—to promote and ensure scientific interactions.
|Cancer Control and Outcomes Program|
|Therapeutic Studies Program|
|Biomarker Sciences Program|